Jeevan Scientific Technology Ltd

Jeevan Scienti. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Jeevan Scientific Technology Ltd

₹ 52.4 0.02%
26 Apr - close price
jeevanscientific.com BSE: 538837
About

Jeevan Scientific Technology Limited established in 1999, is a clinical research organization with a focus on Pharmacovigilance (PV- tracking and reporting adverse drug reactions after drug launch) & clinical trial business (CT). Its target market is small and medium-sized pharma companies for PV & for CT it focuses on both domestic & international markets. [1]

Key Points

Contract Research Organisation[1]
The company forayed into the Clinical research space in 2014 with the aim of providing quality and cost-effective services to Pharma and biotech companies across the globe and now primarily focuses on specialty drugs like biosimilars and is building expertise on the same.

Website BSE
  • Market Cap ₹ 81.2 Cr.
  • Current Price ₹ 52.4
  • High / Low ₹ 70.9 / 38.6
  • Stock P/E
  • Book Value ₹ 31.6
  • Dividend Yield 0.00 %
  • ROCE -4.42 %
  • ROE -6.20 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 38.7%
  • Company might be capitalizing the interest cost
  • Debtor days have increased from 90.4 to 118 days.
  • Working capital days have increased from 88.8 days to 154 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Miscellaneous

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
15.79 15.37 16.20 18.65 21.02 11.92 10.33 7.97 9.95 7.93 10.39 8.06 10.13
7.48 10.49 10.32 12.39 14.29 14.04 9.04 8.39 8.49 8.96 8.36 7.46 9.12
Operating Profit 8.31 4.88 5.88 6.26 6.73 -2.12 1.29 -0.42 1.46 -1.03 2.03 0.60 1.01
OPM % 52.63% 31.75% 36.30% 33.57% 32.02% -17.79% 12.49% -5.27% 14.67% -12.99% 19.54% 7.44% 9.97%
0.23 0.09 0.09 0.33 0.39 5.12 0.21 0.31 0.28 0.27 0.30 0.26 -0.11
Interest 0.59 0.15 0.27 0.28 0.22 0.20 0.27 0.22 0.21 0.28 0.23 0.26 0.15
Depreciation 1.00 0.99 1.00 1.00 0.98 0.71 1.05 1.26 1.34 1.42 1.47 1.43 1.40
Profit before tax 6.95 3.83 4.70 5.31 5.92 2.09 0.18 -1.59 0.19 -2.46 0.63 -0.83 -0.65
Tax % 17.55% -0.26% 29.36% 29.76% 27.87% 70.81% -116.67% 25.16% 73.68% 6.10% 19.05% 25.30% 24.62%
5.73 3.84 3.32 3.74 4.27 0.62 0.38 -1.19 0.05 -2.31 0.51 -0.61 -0.49
EPS in Rs 3.74 2.51 2.17 2.44 2.79 0.41 0.25 -0.78 0.03 -1.49 0.34 -0.39 -0.31
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
17.39 18.21 20.39 26.13 23.94 46.90 67.79 36.18 36.51
15.59 15.01 16.96 20.27 30.02 29.41 51.02 34.87 33.90
Operating Profit 1.80 3.20 3.43 5.86 -6.08 17.49 16.77 1.31 2.61
OPM % 10.35% 17.57% 16.82% 22.43% -25.40% 37.29% 24.74% 3.62% 7.15%
0.37 0.58 0.92 1.00 2.50 2.39 5.91 1.07 0.72
Interest 1.28 1.54 1.87 2.36 3.04 2.26 0.96 0.99 0.92
Depreciation 0.68 1.23 2.12 3.13 3.92 3.97 3.69 5.07 5.72
Profit before tax 0.21 1.01 0.36 1.37 -10.54 13.65 18.03 -3.68 -3.31
Tax % 104.76% 10.89% 69.44% 18.25% 18.60% 13.99% 33.78% 16.58%
-0.01 0.90 0.11 1.11 -8.59 11.74 11.94 -3.07 -2.90
EPS in Rs -0.02 0.97 0.10 0.73 -5.61 7.67 7.80 -1.98 -1.85
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 6.52% 15.38% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 12%
3 Years: 15%
TTM: -9%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 18%
TTM: -1950%
Stock Price CAGR
10 Years: %
5 Years: 12%
3 Years: -15%
1 Year: -5%
Return on Equity
10 Years: %
5 Years: 6%
3 Years: 15%
Last Year: -6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 6.04 9.28 11.46 15.30 15.30 15.30 15.30 15.48 15.48
Reserves -2.27 7.60 7.42 16.53 7.92 19.72 35.28 32.71 33.36
11.08 8.45 18.78 18.15 17.95 10.34 12.55 10.09 12.32
5.56 5.56 11.72 11.32 12.70 20.62 14.75 7.64 7.59
Total Liabilities 20.41 30.89 49.38 61.30 53.87 65.98 77.88 65.92 68.75
8.67 16.35 28.17 32.59 30.54 27.38 19.07 24.97 23.00
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.90 5.51
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
11.74 14.54 21.21 28.71 23.33 38.60 58.81 39.05 40.24
Total Assets 20.41 30.89 49.38 61.30 53.87 65.98 77.88 65.92 68.75

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
3.55 -5.62 5.65 4.04 -0.01 4.95 19.56 -8.88
-3.63 -8.90 -14.35 -7.87 -1.90 -0.80 -1.20 -6.93
0.23 14.57 9.86 6.08 0.44 -0.13 5.67 -7.06
Net Cash Flow 0.15 0.05 1.17 2.25 -1.47 4.02 24.03 -22.88

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 151.96 227.10 291.79 205.20 104.29 112.46 40.97 117.83
Inventory Days 72.11 105.50
Days Payable 98.78 322.56
Cash Conversion Cycle 151.96 227.10 291.79 205.20 104.29 112.46 14.30 -99.23
Working Capital Days 103.48 139.91 161.47 98.34 11.59 57.43 54.97 154.05
ROCE % 12.69% 7.08% 8.51% -16.39% 36.77% 27.58% -4.42%

Shareholding Pattern

Numbers in percentages

4 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
38.11% 38.11% 38.11% 36.15% 36.47% 36.47% 36.85% 38.44% 38.48% 38.48% 38.48% 38.70%
61.89% 61.89% 61.89% 63.85% 63.53% 63.54% 63.17% 61.55% 61.52% 61.51% 61.51% 61.29%
No. of Shareholders 3,9995,4995,8136,1446,4396,4496,2956,0615,9115,9335,7275,749

Documents

Announcements

Annual reports